{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:12:41Z","timestamp":1792811561073,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Human Immunodeficiency Virus\n                      <jats:bold>(<\/jats:bold>\n                      HIV) infection remains a public health concern in many countries. The increased life expectancy in the post-Antiretroviral Therapy (ART) era has led to an increased risk of cardiovascular disease and death among Persons Living with HIV (PLHIV). Hypertension remains a significant risk factor for cardiovascular disease among PLHIV. Some studies have suggested associations between hypertension among PLHIV and HIV-related health factors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the prevalence of hypertension among PLHIV on antiretroviral medications and examine its association with HIV-related health factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted among attendants at an adult HIV clinic. 362 study participants were selected by systematic sampling. Data on hypertension diagnosis, HIV-related health factors, sociodemographic and other traditional cardiovascular risk factors were collected using a standardized questionnaire and patient chart review. Multivariate logistic regression model was used to determine the association between hypertension and HIV-related factors, adjusting for other risk factors for hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The mean age of participants was 47.9\u00a0years and majority of participants were female (77.1%). 42% of study participants had been on antiretroviral medications for\u2009&gt;\u200910\u00a0years. The prevalence of hypertension was 17.4%. Age\u2009&gt;\u200950\u00a0years was associated with higher odds of hypertension (aOR: 3.75, 95%CI 1.68, 8.55, p-value: 0.002). BMI in overweight and obese categories, and a history of comorbid medical conditions (diabetes, hyperlipidemia) were also associated with higher odds of hypertension (aOR: 3. 76, 95%CI 1.44, 9.81, p-value: 0.007), (aOR: 3.17, 95%CI 1.21, 8.32, p-value: 0.019) and (aOR: 14.25, 95%CI 7.41, 27.41, p-value:\u2009&lt;\u20090.001) respectively. No HIV-related health factors were associated with hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Hypertension was a common condition among PLHIV on antiretroviral medications. No HIV-related health factors were associated with hypertension. Traditional risk factors associated with hypertension were increased age\u2009&gt;\u200950\u00a0years, increased BMI, and a history of comorbid medical conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12981-023-00576-2","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T02:02:28Z","timestamp":1704938548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Hypertension among persons living with HIV\/AIDS and its association with HIV-related health factors"],"prefix":"10.1186","volume":"21","author":[{"given":"Mawulorm K. I.","family":"Denu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritika","family":"Revoori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maame Araba E.","family":"Buadu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwakemi","family":"Oladele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kofi Poku","family":"Berko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"key":"576_CR1","unstructured":"World Health Organization (WHO). HIV\/AIDS Fact sheet. Accessed 10 July 2022."},{"issue":"6","key":"576_CR2","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.mayocp.2015.03.008","volume":"90","author":"NW Cummins","year":"2015","unstructured":"Cummins NW, Badley AD. Can HIV be cured and should we Try? Mayo Clin Proc. 2015;90(6):705\u20139. https:\/\/doi.org\/10.1016\/j.mayocp.2015.03.008.","journal-title":"Mayo Clin Proc"},{"key":"576_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/HYPERTENSIONAHA.118.10893","volume":"72","author":"SA Fahme","year":"2018","unstructured":"Fahme SA, Bloomfield GS, Peck R. Hypertension in HIV-infected adults: novel pathophysiologic mechanisms. Hypertension. 2018;72:44\u201355. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.118.10893.","journal-title":"Hypertension"},{"key":"576_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.amjcard.2015.10.030","volume":"117","author":"MJ Feinstein","year":"2016","unstructured":"Feinstein MJ, Bahiru E, Achenbach C, et al. Patterns of cardiovascular mortality for HIV-infected adults in the United States: 1999 to 2013. Am J Cardiol. 2016;117:214\u201320.","journal-title":"Am J Cardiol"},{"issue":"396","key":"576_CR5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/QAI.0b013e3182847cd0","volume":"62","author":"R N\u00fcesch","year":"2013","unstructured":"N\u00fcesch R, Wang Q, Elzi L, Bernasconi E, Weber R, Cavassini M, Vernazza P, Thurnheer MC, Calmy A, Battegay M, Bucher HC. Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS). J Acquir Immune Defic Syndr. 2013;62(396):404. https:\/\/doi.org\/10.1097\/QAI.0b013e3182847cd0.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"576_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1310\/hct1102-100","volume":"11","author":"NF Onen","year":"2010","unstructured":"Onen NF, Overton ET, Seyfried W, Stumm ER, Snell M, Mondy K, Tebas P. Aging and HIV infection: a comparison between older HIV-infected persons and the general population. HIV Clin Trials. 2010;11:100\u20139. https:\/\/doi.org\/10.1310\/hct1102-100.","journal-title":"HIV Clin Trials"},{"key":"576_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12916-014-0125-2","volume":"12","author":"RN Peck","year":"2014","unstructured":"Peck RN, Shedafa R, Kalluvya S, Downs JA, Todd J, Suthanthiran M, Fitzgerald DW, Kataraihya JB. Hypertension, kidney disease, HIVand antiretroviral therapy among Tanzanian adults: a cross-sectional study. BMC Med. 2014;12:125. https:\/\/doi.org\/10.1186\/s12916-014-0125-2.","journal-title":"BMC Med"},{"key":"576_CR8","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1097\/01.hjh.0000059071.43904.dc","volume":"21","author":"C Gazzaruso","year":"2003","unstructured":"Gazzaruso C, Bruno R, Garzaniti A, Giordanetti S, Fratino P, Sacchi P, Filice G. Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome. J Hypertens. 2003;21:1377\u201382. https:\/\/doi.org\/10.1097\/01.hjh.0000059071.43904.dc.","journal-title":"J Hypertens"},{"issue":"11","key":"576_CR9","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1111\/jch.14046","volume":"22","author":"KC Ferdinand","year":"2020","unstructured":"Ferdinand KC. Uncontrolled hypertension in sub-Saharan Africa: Now is the time to address a looming crisis. J Clin Hypertens. 2020;22(11):2111\u20133. https:\/\/doi.org\/10.1111\/jch.14046.","journal-title":"J Clin Hypertens"},{"issue":"205","key":"576_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/cid\/ciw285","volume":"63","author":"RA Zoest","year":"2016","unstructured":"Zoest RA, Wit FW, Kooij KW, van der Valk M, Schouten J, Kootstra NA, Wiersinga WJ, Prins M, van den Born BJ, Reiss P. Higher prevalence of hypertension in HIV-1-infected patients on combination antiretroviral therapy is associated with changes in body composition and prior stavudine exposure. Clin Infect Dis. 2016;63(205):213. https:\/\/doi.org\/10.1093\/cid\/ciw285.","journal-title":"Clin Infect Dis"},{"key":"576_CR11","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.jash.2017.06.004","volume":"11","author":"Y Xu","year":"2017","unstructured":"Xu Y, Chen X, Wang K. Global prevalence of hypertension among people living with HIV: a systematic review and meta-analysis. J Am Soc Hypertens. 2017;11:530\u201340. https:\/\/doi.org\/10.1016\/j.jash.2017.06.004.","journal-title":"J Am Soc Hypertens"},{"key":"576_CR12","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/ije\/dyt198","volume":"42","author":"DG Dillon","year":"2013","unstructured":"Dillon DG, Gurdasani D, Riha J, et al. african partnership for chronic disease research (APCDR). association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis. Int J Epidemiol. 2013;42:1754\u201371. https:\/\/doi.org\/10.1093\/ije\/dyt198.","journal-title":"Int J Epidemiol."},{"issue":"1","key":"576_CR13","doi-asserted-by":"publisher","first-page":"20509","DOI":"10.1038\/s41598-022-24997-7.","volume":"12","author":"D Harimenshi","year":"2022","unstructured":"Harimenshi D, Niyongabo T, Preux PM, Aboyans V, Desormais I. Hypertension and associated factors in HIV-infected patients receiving antiretroviral treatment in Burundi: a cross-sectional study. Sci Rep. 2022;12(1):20509. https:\/\/doi.org\/10.1038\/s41598-022-24997-7.","journal-title":"Sci Rep"},{"issue":"39","key":"576_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.11604\/pamj.2021.39.237.29718.","volume":"12","author":"R Musekwa","year":"2021","unstructured":"Musekwa R, Hamooya BM, Koethe JR, Nzala S, Masenga SK. Prevalence and correlates of hypertension in HIV-positive adults from the Livingstone Central Hospital, Zambia. Pan Afr Med J. 2021;12(39):237. https:\/\/doi.org\/10.11604\/pamj.2021.39.237.29718.","journal-title":"Pan Afr Med J"},{"key":"576_CR15","doi-asserted-by":"publisher","first-page":"e42624","DOI":"10.1371\/journal.pone.0042624","volume":"7","author":"E Blodget","year":"2012","unstructured":"Blodget E, Shen C, Aldrovandi G, Rollie A, Gupta SK, Stein JH, Dub\u00e9 MP. Relationship between microbial translocation and endothelial function in HIV infected patients. PLoS One. 2012;7:e42624. https:\/\/doi.org\/10.1371\/journal.pone.0042624.","journal-title":"PLoS One"},{"key":"576_CR16","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/01.aids.0000222074.45372.00","volume":"20","author":"HM Crane","year":"2006","unstructured":"Crane HM, Van Rompaey SE, Kitahata MM. Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy. AIDS. 2006;20:1019\u201326. https:\/\/doi.org\/10.1097\/01.aids.0000222074.45372.00.","journal-title":"AIDS"},{"key":"576_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/sj.jhh.1001785","volume":"19","author":"LE Bautista","year":"2005","unstructured":"Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens. 2005;19:149\u201354. https:\/\/doi.org\/10.1038\/sj.jhh.1001785.","journal-title":"J Hum Hypertens"},{"key":"576_CR18","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1751-7176.2012.00671.x","volume":"14","author":"P Freitas","year":"2012","unstructured":"Freitas P, Carvalho D, Santos AC, Madureira AJ, Xerinda S, Martinez E, Pereira J, Sarmento A, Medina JL. Central\/Peripheral fat mass ratio is associated with increased risk of hypertension in HIV-infected patients. J Clin Hypertens (Greenwich). 2012;14:593\u2013600. https:\/\/doi.org\/10.1111\/j.1751-7176.2012.00671.x.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"576_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000299","volume":"2","author":"J Wang","year":"2013","unstructured":"Wang J, Wang H, Luo W, Guo C, Wang J, Chen YE, Chang L, Eitzman DT. Leptin-induced endothelial dysfunction is mediated by sympathetic nervous system activity. J Am Heart Assoc. 2013;2: e000299. https:\/\/doi.org\/10.1161\/JAHA.113.000299.","journal-title":"J Am Heart Assoc"},{"key":"576_CR20","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1161\/HYPERTENSIONAHA.116.08258","volume":"69","author":"SB Ascher","year":"2017","unstructured":"Ascher SB, Scherzer R, Peralta CA, Tien PC, Grunfeld C, Estrella MM, Abraham A, Gustafson DR, Nowicki M, Sharma A, Cohen MH, Butch AW, Young MA, Bennett MR, Shlipak MG. Association of kidney function and early kidney injury with incident hypertension in HIV-infected women. Hypertension. 2017;69:304\u201313. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.116.08258.","journal-title":"Hypertension"},{"key":"576_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13098-019-0502-2","volume":"11","author":"OO Todowede","year":"2019","unstructured":"Todowede OO, Sartorius B, Magula N, Schutte AE. Association of predicted 10 years cardiovascular mortality risk with duration of HIV infection and antiretroviral therapy among HIV-infected individuals in Durban. South Africa Diabetol Metab Syndr. 2019;11:105. https:\/\/doi.org\/10.1186\/s13098-019-0502-2.","journal-title":"South Africa Diabetol Metab Syndr"},{"issue":"2019","key":"576_CR22","doi-asserted-by":"publisher","first-page":"4103604","DOI":"10.1155\/2019\/4103604.","volume":"23","author":"T Fiseha","year":"2019","unstructured":"Fiseha T, Belete AG, Dereje H, Dires A. Hypertension in HIV-infected patients receiving antiretroviral therapy in Northeast Ethiopia. Int J Hypertens. 2019;23(2019):4103604. https:\/\/doi.org\/10.1155\/2019\/4103604.","journal-title":"Int J Hypertens"},{"key":"576_CR23","first-page":"87","volume":"33","author":"PJ Pangmekeh","year":"2019","unstructured":"Pangmekeh PJ, Awolu MM, Gustave S, Gladys T, Cumber SN. Association between highly active antiretroviral therapy (HAART) and hypertension in persons living with HIV\/AIDS at the Bamenda regional hospital. Cameroon Pan Afr Med J. 2019;33:87.","journal-title":"Cameroon Pan Afr Med J"},{"issue":"1","key":"576_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/QCO.0000000000000616","volume":"33","author":"AR Eckard","year":"2020","unstructured":"Eckard AR, McComsey GA. Weight gain and integrase inhibitors. Curr Opin Infect Dis. 2020;33(1):10\u20139.","journal-title":"Curr Opin Infect Dis"},{"issue":"22","key":"576_CR25","doi-asserted-by":"publisher","first-page":"1691474","DOI":"10.1155\/2018\/1691474.","volume":"2018","author":"CA Dimala","year":"2018","unstructured":"Dimala CA, Kadia BM, Kemah BL, Tindong M, Choukem SP. Association between CD4 cell count and blood pressure and its variation with body mass index categories in HIV-infected patients. Int J Hypertens. 2018;2018(22):1691474. https:\/\/doi.org\/10.1155\/2018\/1691474.","journal-title":"Int J Hypertens"},{"issue":"8","key":"576_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.023811","volume":"15","author":"A Gebrie","year":"2020","unstructured":"Gebrie A. Hypertension among people living with human immunodeficiency virus receiving care at referral hospitals of Northwest Ethiopia: a cross-sectional study. PLoS ONE. 2020;15(8): e0238114. https:\/\/doi.org\/10.1371\/journal.pone.023811.","journal-title":"PLoS ONE"},{"issue":"1","key":"576_CR27","doi-asserted-by":"publisher","first-page":"1321279","DOI":"10.1080\/16549716.2017.1321279","volume":"10","author":"NR Mosha","year":"2017","unstructured":"Mosha NR, Mahande M, Juma A, Mboya I, Peck R, Urassa M, Michael D, Todd J. Prevalence, awareness and factors associated with hypertension in North West Tanzania. Glob Health Action. 2017;10(1):1321279.","journal-title":"Glob Health Action"},{"issue":"7","key":"576_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0253742","volume":"16","author":"A Dzudie","year":"2021","unstructured":"Dzudie A, Hoover D, Kim H-Y, Ajeh R, Adedimeji A, Shi Q, et al. Hypertension among people living with HIV\/AIDS in Cameroon: a cross-sectional analysis from Central Africa international epidemiology databases to evaluate AIDS. PLoS ONE. 2021;16(7): e0253742. https:\/\/doi.org\/10.1371\/journal.pone.0253742.","journal-title":"PLoS ONE"},{"issue":"41","key":"576_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.11604\/pamj.2022.41.153.21809","volume":"21","author":"IL Jackson","year":"2022","unstructured":"Jackson IL, Lawrence SM, Igwe CN, Ukwe CV, Okonta MJ. Prevalence and control of hypertension among people living with HIV receiving care at a Nigerian hospital. Pan Afr Med J. 2022;21(41):153. https:\/\/doi.org\/10.11604\/pamj.2022.41.153.21809.","journal-title":"Pan Afr Med J"},{"key":"576_CR30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40885-022-00230-5","volume":"29","author":"R Migisha","year":"2023","unstructured":"Migisha R, Ario AR, Kadobera D, et al. High blood pressure and associated factors among HIV-infected young persons aged 13 to 25 years at selected health facilities in Rwenzori region, western Uganda, September\u2013October 2021. Clin Hypertens. 2023;29:6. https:\/\/doi.org\/10.1186\/s40885-022-00230-5.","journal-title":"Clin Hypertens"},{"issue":"18","key":"576_CR31","doi-asserted-by":"publisher","first-page":"11196","DOI":"10.3390\/ijerph191811196","volume":"19","author":"U Tsuro","year":"2022","unstructured":"Tsuro U, Oladimeji KE, Pulido-Estrada G-A, Apalata TR. Risk Factors attributable to hypertension among hiv-infected patients on antiretroviral therapy in selected Rural Districts of the Eastern Cape Province, South Africa. Int J Environ Res Public Health. 2022;19(18):11196. https:\/\/doi.org\/10.3390\/ijerph191811196.","journal-title":"Int J Environ Res Public Health"},{"key":"576_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0205985","volume":"13","author":"OA Sanuade","year":"2018","unstructured":"Sanuade OA, Boatemaa S, Kushitor MK. Hypertension prevalence, awareness, treatment and control in Ghanaian population: evidence from the Ghana demographic and health survey. PLoS ONE. 2018;13:1\u201318.","journal-title":"PLoS ONE"},{"issue":"11","key":"576_CR33","doi-asserted-by":"publisher","first-page":"204800402210755","DOI":"10.1177\/20480040221075521.PMID:35111304;PMCID:PMC8801650","volume":"28","author":"EK Tannor","year":"2022","unstructured":"Tannor EK, Nyarko OO, Adu-Boakye Y, Owusu Konadu S, Opoku G, Ankobea-Kokroe F, Opare Addo M, Amuzu EX, Ansah GJ, Appiah-Boateng K, Ansong D. Burden of hypertension in Ghana\u2014analysis of awareness and screening campaign in the Ashanti Region of Ghana. JRSM Cardiovasc Dis. 2022;28(11):20480040221075520. https:\/\/doi.org\/10.1177\/20480040221075521.PMID:35111304;PMCID:PMC8801650.","journal-title":"JRSM Cardiovasc Dis"},{"issue":"8","key":"576_CR34","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.jash.2017.06.004","volume":"11","author":"Y Xu","year":"2017","unstructured":"Xu Y, Chen X, Wang K. Global prevalence of hypertension among people living with HIV: a systematic review and meta-analysis. J Am Soc Hypertens. 2017;11(8):530\u201340. https:\/\/doi.org\/10.1016\/j.jash.2017.06.004.","journal-title":"J Am Soc Hypertens"},{"issue":"2","key":"576_CR35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5539\/gjhs.v6n2p58.PMID:24576366;PMCID:PMC4825229","volume":"6","author":"N Hejazi","year":"2013","unstructured":"Hejazi N, Huang MS, Lin KG, Choong LC. Hypertension among HIV-infected adults receiving highly active antiretroviral therapy (HAART) in Malaysia. Glob J Health Sci. 2013;6(2):58\u201371. https:\/\/doi.org\/10.5539\/gjhs.v6n2p58.PMID:24576366;PMCID:PMC4825229.","journal-title":"Glob J Health Sci"},{"issue":"4","key":"576_CR36","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/QAI.0000000000000168","volume":"66","author":"M Myerson","year":"2014","unstructured":"Myerson M, Poltavskiy E, Armstrong EJ, Kim S, Sharp V, Bang H. Prevalence, treatment, and control of dyslipidemia and hypertension in 4278 HIV outpatients. J Acquir Immune Defic Syndr. 2014;66(4):370\u20137. https:\/\/doi.org\/10.1097\/QAI.0000000000000168.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"576_CR37","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1001\/jama.294.4.466","volume":"294","author":"DM Lloyd-Jones","year":"2005","unstructured":"Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA. 2005;294(4):466\u201372. https:\/\/doi.org\/10.1001\/jama.294.4.466.","journal-title":"JAMA"},{"key":"576_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/clc.23303","volume":"43","author":"E Oliveros","year":"2020","unstructured":"Oliveros E, Patel H, Kyung S, et al. Hypertension in older adults: assessment, management, and challenges. Clin Cardiol. 2020;43:99\u2013107. https:\/\/doi.org\/10.1002\/clc.23303.","journal-title":"Clin Cardiol"},{"issue":"1","key":"576_CR39","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1515\/med-2021-0014.PMID:33585690;PMCID:PMC7862997","volume":"16","author":"W Qiao","year":"2021","unstructured":"Qiao W, Zhang X, Kan B, Vuong AM, Xue S, Zhang Y, Li B, Zhao Q, Guo D, Shen X, Yang S. Hypertension, BMI, and cardiovascular and cerebrovascular diseases. Open Med (Wars). 2021;16(1):149\u201355. https:\/\/doi.org\/10.1515\/med-2021-0014.PMID:33585690;PMCID:PMC7862997.","journal-title":"Open Med (Wars)"},{"key":"576_CR40","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1161\/HYPERTENSIONAHA.117.10546","volume":"71","author":"V Tsimihodimos","year":"2018","unstructured":"Tsimihodimos V, Gonzalez-Villalpando C, Meigs JB, Ferrannini E. Hypertension and diabetes mellitus: coprediction and time trajectories. Hypertension. 2018;71:422\u20138.","journal-title":"Hypertension"},{"key":"576_CR41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1161\/01.HYP.0000196306.42418.0e","volume":"47","author":"RO Halperin","year":"2006","unstructured":"Halperin RO, Sesso HD, Ma J, Buring JE, Stampfer MJ, Gaziano JM. Dyslipidemia and the risk of incident hypertension in men. Hypertension. 2006;47:45\u201350.","journal-title":"Hypertension"},{"issue":"1","key":"576_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/1545109711418361","volume":"11","author":"S Medina-Torne","year":"2012","unstructured":"Medina-Torne S, Ganesan A, Barahona I, Crum-Cianflone NF. Hypertension is common among HIV-infected persons, but not associated with HAART. J Int Assoc Phys AIDS Care. 2012;11(1):20\u20135. https:\/\/doi.org\/10.1177\/1545109711418361.","journal-title":"J Int Assoc Phys AIDS Care"},{"issue":"5","key":"576_CR43","first-page":"453","volume":"80","author":"MG Zanuzzi","year":"2020","unstructured":"Zanuzzi MG, Cattaneo MJ, L\u00f3pez SM, P\u00e9rez Maure ML\u00c1, Romero CA. Hipertensi\u00f3n y s\u00edndrome metab\u00f3lico en pacientes con virus de la inmunodeficiencia-humana Hypertension and metabolic syndrome in HIV infected patients. Medicina (B Aires). 2020;80(5):453\u201361.","journal-title":"Medicina (B Aires)"},{"key":"576_CR44","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/QAI.0000000000002067","volume":"81","author":"M Muddu","year":"2019","unstructured":"Muddu M, Tusubira AK, Sharma SK, Akiteng AR, Ssinabulya I, Schwartz JI. Integrated hypertension and HIV care cascades in an HIV treatment program in eastern uganda: a retrospective cohort study. JAIDS J Acquir Immune Defic Syndr. 2019;81:552\u201361.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"576_CR45","doi-asserted-by":"publisher","first-page":"1750216","DOI":"10.1080\/16549716.2020.1750216","volume":"13","author":"S Ameh","year":"2020","unstructured":"Ameh S. Evaluation of an integrated HIV and hypertension management model in rural South Africa: a mixed methods approach. Glob Health Action. 2020;13:1750216.","journal-title":"Glob Health Action."}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-023-00576-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-023-00576-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-023-00576-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T02:06:32Z","timestamp":1704938792000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-023-00576-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["576"],"URL":"https:\/\/doi.org\/10.1186\/s12981-023-00576-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3449850\/v1","asserted-by":"object"}]},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,11]]},"assertion":[{"value":"15 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Korle Bu Teaching Hospital Institutional Review Board (IRB) reviewed and approved the study protocol on 27th May, 2020. (Protocol Number KBTH-IRB \/00047\/2020). All study methods were carried out in accordance with relevant guidelines and regulations including the Declaration of Helsinki. Informed consent was obtained from all study subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}